Who Paid My Doc
Impella
Device Cardiology/Vascular Diseases
General payments
$38,173,680
Research payments
$4,860,032
Through program year 2024, $38,173,680 in general payments and $4,860,032 in research payments were reported against Impella (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $9,988,196 | 55,914 |
| 2024 | Research | $1,015,559 | 407 |
| 2023 | General | $8,591,856 | 32,963 |
| 2023 | Research | $1,080,074 | 516 |
| 2022 | General | $6,335,917 | 24,287 |
| 2022 | Research | $1,217,174 | 175 |
| 2021 | General | $4,395,175 | 16,604 |
| 2021 | Research | $650,782 | 54 |
| 2020 | General | $3,724,229 | 10,426 |
| 2020 | Research | $92,592 | 26 |
| 2019 | General | $5,138,309 | 19,142 |
| 2019 | Research | $803,851 | 53 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 190 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 54 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
159,336 general · 1,231 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.